News for Seagen Inc. (SGEN)

However, this abrupt rally appears to be a singular occurrence – competitors such as Pfizer (NYSE: PFE), Sarepta Therapeutics (NASDAQ: SRPT), and...

There's little doubt these pharmaceutical companies' costs will soon be rising at least a little.

**media[619369]**

Entering trading on Monday, the S&P 500 has declined around 6% since the start of the year. Three stocks that are down over 10% this year and trading at low earnings multiples are Pfizer (NYSE: PFE), PayPal (NASDAQ: PYPL), and Builders FirstSource (NYSE: BLDR). Investors haven't been all that bullish on Pfizer this year -- it's down 13% thus far in 2025.

Pfizer missed first quarter earnings Thursday amid a volatile macro environment.

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.( TARA), a clinical-stage company developing transformative therapies for the treatment

**media[596099]**

Though the stock market is still historically pricey, a few phenomenal bargains have cropped up.

Try not to let market volatility bring you down. Instead, let dividend stocks make you happy. These high-yield dividend stocks will pay you between 3% and 7% to hold them.

Buying stock in great companies when they are dealing with some short-term issue that creates stock price weakness can set investors up for big gains down the road. As long as the business is still in good shape, adding it to your portfolio when it's trading at a sizable discount can look like a brilliant move in the future. Stocks normally trade at discounts when there are concerns or question marks about the company's future performance.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, to

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China's National Medical Products Administration (NMPA) has accepted the Biologics License Appl

/PRNewswire-PRWeb/ -- Ambrosia Biosciences Inc. ("Ambrosia"), today announced the appointment of Jason Haddock to the Board of Directors and as Chair of the...

We recently published a list of 10 Best Very Cheap Stocks To Buy Right Now. In this article, we are going to take a look at where Pfizer Inc.

The overall market atmosphere has been moderately negative since the new tariffs from the US.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced positive topline results from the China subpopulation of the global Phase 3 innovaTV 301 study, demo

Zai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer

Biocom California Appoints New Members to its Board of Directors

A new year brings with it new opportunities to grow your wealth on Wall Street.